TNF and ankylosing spondylitis: Tumor necrosis factor-alpha (TNF-α) inhibitors have revolutionized the treatment of rheumatic diseases including rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA).